David M. Knott’s Viking Therapeutics VKTX Stock Holding History

David M. Knott’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$1.31M	Hold	208,102	–	–	0.47%	50
2021 Q2	$1.25M	Hold	208,102	–	–	0.44%	51
2021 Q1	$1.32M	Sell	208,102 -10,000	-5%	-$70.4K	0.56%	45
2020 Q4	$1.23M	Hold	218,102	–	–	0.56%	40
2020 Q3	$1.27M	Hold	218,102	–	–	0.74%	31
2020 Q2	$1.57M	Hold	218,102	–	–	0.86%	29
2020 Q1	$1.02M	Hold	218,102	–	–	0.64%	29
2019 Q4	$1.75M	Hold	218,102	–	–	0.71%	27
2019 Q3	$1.5M	Hold	218,102	–	–	0.63%	32
2019 Q2	$1.81M	Hold	218,102	–	–	0.76%	24
2019 Q1	$2.17M	Sell	218,102 -20,000	-8%	-$167K	0.86%	24
2018 Q4	$1.82M	Buy	238,102 +1,502	+0.6%	+$18K	0.86%	24
2018 Q3	$4.12M	Sell	236,600 -10,000	-4%	-$119K	1.34%	19
2018 Q2	$2.34M	Buy	246,600 +4,600	+2%	+$30.6K	0.88%	27
2018 Q1	$1.06M	Buy	242,000 +10,000	+4%	+$55.3K	0.44%	31
2017 Q4	$942K	Buy	+232,000	New	+$674K	0.37%	36

Other funds holding VKTX

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

David M. Knott's VKTX Position: Q3 2021 in Review

David M. Knott held its Viking Therapeutics (VKTX) position steady in Q3 2021 at 208,102 shares worth $1.31M. The position accounts for 0.47% of the portfolio, ranked #50.

David M. Knott first reported a position in VKTX in Q4 2017 and has held it in 16 quarters since. The position peaked at $4.12M in Q3 2018. 134 funds tracked by Wall St. Rank hold VKTX as of Q3 2021.

David M. Knott held 208,102 shares of Viking Therapeutics worth $1.31M as of Q3 2021.
David M. Knott left its Viking Therapeutics share count unchanged in Q3 2021.
Viking Therapeutics made up 0.47% of David M. Knott's portfolio in Q3 2021, its #50 holding.
David M. Knott first reported a position in Viking Therapeutics in Q4 2017 and has held it in 16 quarters since.
David M. Knott's Viking Therapeutics position peaked at $4.12M in Q3 2018.
134 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2021.

Based on David M. Knott's 13F filing for Q3 2021, filed 12 Nov 2021.